Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.
Aideen M CampbellMelanie MorrisRebecca GallagherRuth BoydHazel CarsonD Paul HarkinEwa WielogorskaChristopher ElliottKienan I SavageStuart A McIntoshPublished in: BMJ open (2018)
EudraCT: 2016-001087-11; Pre-results.